Skip to main navigation Skip to search Skip to main content

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

A. Michael Lincoff, John A. Bittl, Neal S. Kleiman, Ian J. Sarembock, J. Daniel Jackman, Sameer Mehta, Mark A. Tannenbaum, Alan L. Niederman, William B. Bachinsky, J. Tift-Mann, H. Graham Parker, Dean J. Kereiakes, Robert A. Harrington, Frederick Feit, Elizabeth S. Maierson, Derek P. Chew, Eric J. Topol

Research output: Contribution to journal › Article › peer-review

225   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science